Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.
Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE. Lanctôt KL, et al. Among authors: lerner aj. Am J Geriatr Psychiatry. 2021 Jan;29(1):81-89. doi: 10.1016/j.jagp.2020.05.020. Epub 2020 May 27. Am J Geriatr Psychiatry. 2021. PMID: 32565008 Free PMC article. Clinical Trial.
Delirium in Alzheimer disease.
Lerner AJ, Hedera P, Koss E, Stuckey J, Friedland RP. Lerner AJ, et al. Alzheimer Dis Assoc Disord. 1997 Mar;11(1):16-20. doi: 10.1097/00002093-199703000-00004. Alzheimer Dis Assoc Disord. 1997. PMID: 9071440
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease.
Ewers M, Schmitz S, Hansson O, Walsh C, Fitzpatrick A, Bennett D, Minthon L, Trojanowski JQ, Shaw LM, Faluyi YO, Vellas B, Dubois B, Blennow K, Buerger K, Teipel SJ, Weiner M, Hampel H; Alzheimer's Disease Neuroimaging Initiative. Ewers M, et al. Neurobiol Aging. 2012 Aug;33(8):1599-608. doi: 10.1016/j.neurobiolaging.2011.05.005. Epub 2011 Jun 17. Neurobiol Aging. 2012. PMID: 21684041 Free PMC article.
Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease.
Tariot PN, Schneider LS, Cummings J, Thomas RG, Raman R, Jakimovich LJ, Loy R, Bartocci B, Fleisher A, Ismail MS, Porsteinsson A, Weiner M, Jack CR Jr, Thal L, Aisen PS; Alzheimer's Disease Cooperative Study Group. Tariot PN, et al. Arch Gen Psychiatry. 2011 Aug;68(8):853-61. doi: 10.1001/archgenpsychiatry.2011.72. Arch Gen Psychiatry. 2011. PMID: 21810649 Free PMC article. Clinical Trial.
Chronic divalproex sodium use and brain atrophy in Alzheimer disease.
Fleisher AS, Truran D, Mai JT, Langbaum JB, Aisen PS, Cummings JL, Jack CR Jr, Weiner MW, Thomas RG, Schneider LS, Tariot PN; Alzheimer's Disease Cooperative Study. Fleisher AS, et al. Neurology. 2011 Sep 27;77(13):1263-71. doi: 10.1212/WNL.0b013e318230a16c. Epub 2011 Sep 14. Neurology. 2011. PMID: 21917762 Free PMC article. Clinical Trial.
Empirical derivation of the reference region for computing diagnostic sensitive ¹⁸fluorodeoxyglucose ratios in Alzheimer's disease based on the ADNI sample.
Rasmussen JM, Lakatos A, van Erp TG, Kruggel F, Keator DB, Fallon JT, Macciardi F, Potkin SG; Alzheimer's Disease Neuroimaging Initiative. Rasmussen JM, et al. Biochim Biophys Acta. 2012 Mar;1822(3):457-66. doi: 10.1016/j.bbadis.2011.09.008. Epub 2011 Sep 19. Biochim Biophys Acta. 2012. PMID: 21958592 Free PMC article.
325 results